NYSE · Stocky rates: Avoid

Teladoc Health, Inc. (TDOC)

$5.82 ▲ +0.52% as of 6 Oct, 14:55

Stocky turns companies like Teladoc Health, Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
33
/ 100
Avoid

What Stocky thinks

Stocky rates Teladoc Health, Inc. at 33/100 based on business quality, leadership alignment, valuation.

Compounder Score
28/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
44/100
Founder-led, insider ownership, capital allocation history.
Moat Score
25/100
Competitive advantage — pricing power, switching costs, network effects.
Resilience
50/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
28/100
Valuation vs peers and history — is this a good price to pay?
B
Average — worth keeping an eye on its debt or profit swings.

How safely Teladoc Health, Inc. is financed, graded A++ (strongest) to C from the last five years of accounts: debt against earnings, interest cover, cash against debt, how high and steady profit margins are, return on capital, and whether it generated cash every year. Not part of the Stocky score.

What Stocky gives investors that other tools don't

Every stock is scored across six dimensions built to answer one question — can this business keep compounding? — without a Bloomberg subscription. Here's the actual snapshot for Teladoc Health, Inc.:

33
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation fused into a single 0–100 number. When you see 33/100, you know instantly whether to dig deeper or skip.

Limited
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

44
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

50
RESILIENCE

Resilience Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

We don't claim a backtest. The top-scoring basket is recorded every month and measured against the S&P 500 from that date onward — judged on what it said before the outcome was known. The record is young, and published as it stands.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

Teladoc Health, Inc. (TDOC) — frequently asked

Is Teladoc Health, Inc. (TDOC) a good investment right now?

Stocky rates Teladoc Health, Inc. (TDOC) at 33/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation into a single number.

What is TDOC's Stocky Verdict?

TDOC's current Stocky Verdict is 33/100, placing it in the "Avoid" band. This composite combines a 28/100 Compounder score, 44/100 Leadership, 25/100 Moat rating.

Does Teladoc Health, Inc. have a competitive moat?

Teladoc Health, Inc. rates Limited moat (25/100 Moat Score) — based on 10-year return-on-invested-capital, pricing power, switching costs and network effects. Wide moats compound; Limited moats erode.

Is Teladoc Health, Inc.'s leadership aligned with shareholders?

Teladoc Health, Inc. scores 44/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to TDOC?

Teladoc Health, Inc.'s Resilience Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Teladoc Health, Inc..

This is just the surface. See the whole picture on Teladoc Health, Inc..

Sign up free and unlock the full analysis on TDOC — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering TDOC — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Resilience Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for TDOC.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how TDOC changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to TDOC?" · "Is TDOC overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
33
/ 100 · Avoid

See Teladoc Health, Inc. the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in TDOC would be worth today.
Practice portfolio
Buy TDOC with virtual money and track it — zero risk.
Free · no real money · learn by doing Open TDOC in Stocky →

Or jump straight to the interactive dashboard for TDOC in the app.